PALLD and central nervous system cancer: Significant differences in survival probability between high, moderate, and low palladin-expressing groups were only observed in brain tumors (the combined glioma cohort comprised by the low-grade glioma (LGG) and GBM sub-cohorts) (χ2Mental-Cox = 115.7, df = 2, p < 0.0001, Figure 1B).